Search News
| 14.25 BATS BZX Real-Time Price As of 10:18am ET |  -0.405 / -2.76%Today’s Change | 11.02 Today|||52-Week Range 17.99 | +0.39% Year-to-Date |
| Previous close | 14.65 |
| Today’s open | 14.58 |
| Day’s range | 14.13 - 14.65 |
| Volume | 25,908 |
| Average volume (3 months) | 993,855 |
| Market cap | $1.7B |
| Earnings growth (last year) | +120.75% |
| Earnings growth (this year) | +71.19% |
| Earnings growth (next 5 years) | +23.03% |
| Revenue growth (last year) | +56.75% |
| P/E ratio | 11.9 |
| Price/Sales | 7.36 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| PCRXPacira Pharmaceutica... | +0.60 | +1.74% |
| EBSEmergent BioSolution... | +0.67 | +1.28% |
| MYOKMyoKardia Inc | +0.80 | +1.61% |
| LXRXLexicon Pharmaceutic... | +0.19 | +2.36% |
| Last reporting date | April 26, 2018 |
| EPS forecast (this quarter) | $0.53 |
| Annual revenue (last year) | $231.0M |
| Annual profit (last year) | $134.1M |
| Net profit margin | 58.06% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
CEO, Chief Financial Officer & Senior VP Eric d'Esparbes |
Chief Scientific Officer & Senior Vice President Theodore J. Witek |
Corporate headquarters Brisbane, California |
